ERCC1 gene silencing A2780 human ovarian cancer cell drug resistance of cisplatin.docVIP

ERCC1 gene silencing A2780 human ovarian cancer cell drug resistance of cisplatin.doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
ERCC1 gene silencing A2780 human ovarian cancer cell drug resistance of cisplatin

 PAGE \* MERGEFORMAT 16 ERCC1 gene silencing A2780 human ovarian cancer cell drug resistance of cisplatin On: Sun Ye-Hong, William FK, Zhu Ying, Li Yuan body [Abstract] Objective: To study the RNA interference gene excision repair cross-complementing 1 (ERCC1) expression, the A2780 ovarian cancer cells resistant to cisplatin changes. Methods: A2780 cells were transfected with siRNA gene ERCC1 and GFPsiRNA, and to give smooth Platinum (to a final concentration of 3 mol / L), were detected by Western blot before and after cisplatin administration ERCC1 protein expression and cisplatin by MTT assay under different concentrations of A2780 cell viability. Results: ERCC1 siRNA transfection the experimental group of protein expression than the control group decreased significantly; ERCC1 siRNA + cisplatin group, ERCC1 expression was weaker than ERCC1 siRNA + PBS group, while GFP siRNA + cisplatin group protein is weaker than GFP siRNA + PBS group; cisplatin (concentration of 0.75 ~ 12 mol / L between) in a concentration dependent manner A2780 cell viability; in the same concentration under the action of cisplatin, compared with the GFPsiRNA, ERCC1siRNA group of cisplatin dose-response curve left. CONCLUSION: Cisplatin ERCC1 gene silencing can inhibit the growth of A2780 cells, and in a certain range of concentration in a concentration dependent manner; ERCC1 is involved in cisplatin resistance have one of the important factors. [Keywords:] RNA interference; excision repair cross-complementing gene 1; cisplatin; drug resistance; ovarian cancer [Abstract] Objective: To investigate the influence of RNA interfering the expression of excision repair cross complementing 1 (ERCC1) gene on the sensitivity of ovarian cancer cell A2780 to Cisplatin.Methods: SiRNA and GFP siRNA was transfected to knock out ERCC1 gene instantaneous and make a control manner respectively. Cisplatin (final concentration of 3mol / L) was given to the knockouted cells. Western blot wa

文档评论(0)

jiupshaieuk12 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

版权声明书
用户编号:6212135231000003

1亿VIP精品文档

相关文档